| dc.identifier.citation | [1] Duffy PE, Mutabingwa TK, Artemisinin combination therapies, Lancet, 367, 2037–2039, 2006. [2] Hale, V., Keasling, JD., Renninger, N and Diagana, N.N, Microbially Derived Artemisinin: A Biotechnology Solution to the Global Problem of Access to Affordable Antimalarial Drugs, Am. J. Trop. Med. Hyg., 77(Suppl 6), 198–202, 2007. [3] Julsing, M. K., Pouderoyen G. V., Veen J. V., Woerdenbag H. J., Bioconversion and combinatorial biosynthesis of selected terpenoids and lignans, Thesis, Department of Pharmaceutical Biology of The University of Groningen, Netherlands, 4, 47-56, 2006. [4] Li Y, Huang H, Wu YL, Qinghaosu (artemisinin)—a fantastic antimalarial drug from a traditional Chinese medicine, In: Liang XT, Fang WS (eds) Medicinal Chemistry of Bioactive Natural Products, Wiley, New York, pp 183–256, 2006. [5] Mutabingwa TK. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy! Acta Trop. 95:305–315. doi: 10.1016/j.actatropica.2005.06.009. [6] Rathore, D., McCutchan, T.F., Sullivan, M., and Kumar, S., Antimalarial drugs: current status and new developments. Expert Opin. Investig. Drugs, 14, 871–883. doi:10.1517/13543784.14.7. 871. PMID:16022576, 2005. [7] White NJ, Qinghaosu (artemisinin): the price of success, Science, 320, 330–334, 2008. [8] Wladyka, B., Puzia, K., and Dubin, A., Efficient Coexpression of a Recombinant Staphopain A and Its Inhibitor Staphostatin A, Biochem. J., 385, 181-187, 2005. | in_ID |
